3．第一次使用本试剂盒时建议先取1-2个样品做预实验。 4．为了您的安全和健康，请穿实验服并戴一次性手套操作。 Doxorubicin hydrochloride是一种拓扑异构酶II(Topoisomerase II，Top2)抑制剂，作用于Hela细胞，IC50为374nM。 储存条件：-20℃，有效期2年，溶入溶剂后-20℃请 ...

Doxorubicin hydrochloride is under clinical development by Skinject and currently in Phase II for Basal Cell Carcinoma (Basal Cell Epithelioma). According to GlobalData, Phase II drugs for Basal Cell ...

Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials is a generic equivalent of Doxil (Liposomal), of Baxter Healthcare Corporation ...

Lupin has launched a generic version of Doxorubicin Hydrochloride Liposome Injection (Doxil) in the US market, treating ovarian cancer, AIDS-related Kaposi's Sarcoma, and multiple myeloma. New Delhi, ...

today announced the ANDA approval of DOXOrubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) from the United States Food and Drug Administration (US FDA).

In this regard, a method using liquid chromatography-tandem mass spectrometry has been established for the detection of doxorubicin hydrochloride liposomes in plasma. Non-clinical pharmacokinetic ...

Department of Clinical and Experimental Medicine, University of Catanzaro “Magna Graecia”, Campus Universitario “S. Venuta” s.n.c., 88100 Catanzaro, Italy ...